Ayşe Ekim

Ayşe Ekim

Auto-generated profile, based on publicly available information

Ayşe Ekim

Special Clinic in Physical Medicine and Rehabilitation, Eskişehir, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
FBFulya Bakilan
Fulya Bakilan
IGİsmail Güneş Gökmen
İsmail Güneş Gökmen
BOBurcu Ortanca
Burcu Ortanca
AUAnıl Uçan
Anıl Uçan
ŞGŞebnem Eker Güvenç
Şebnem Eker Güvenç
AEAyşe Ekim
Ayşe Ekim
Aim There is a lack of an overview of the factors associated with postacute COVID-19 musculoskeletal symptoms. The aims of this study were as follows: 1- to evaluate the most frequent admission symptoms and the frequency of musculoskeletal symptoms in postacute COVID-19 patients; and 2- to determine the related factors with the postacute COVID-19 musculoskeletal symptoms. Methods A total of 280 postacute COVID-19 patients (183 females, 97 males) were enrolled and divided into two groups: 1- patients whose musculoskeletal symptoms initiated with or were aggravated by COVID-19 (n = 240); and 2- patients whose musculoskeletal symptoms did not change with COVID-19 (n = 40). The variables were demographic and treatment data, symptoms on admission, postacute COVID-19 symptoms, laboratory results (complete blood count, erythrocyte sedimentation rate, C-reactive protein, ferritin and d-dimer), chest computed tomography findings and symptoms during acute COVID-19. Results Most of the patients have fatigue (71.8%), spine pain (70.7%) and myalgia (60.7%). The most common pain region was the back (30.4%). The frequency of dyspnoea was 30%, cough 18.5% and chest pain 10.7%. Having any chronic disease (P = .031), the duration of hospital stay (P = .016), frequency of back pain during acute COVID-19 (P = .018), tomography findings and d-dimer (P = .035) levels were significantly higher, and lymphocyte (P = .024) levels were significantly lower in the patients whose symptoms began with or were aggravated by COVID-19. Conclusion Back pain was the most frequent symptom on admission. The most common postacute COVID-19 musculoskeletal symptoms were fatigue, spine pain and myalgia. Lower lymphocyte and higher d-dimer levels, the presence of COVID-19 findings in tomography and back pain during acute COVID-19 infection, higher duration of hospital stay and having chronic diseases were related to post-COVID-19 musculoskeletal symptoms.

1 November 2023 in Journal of Surgery and Medicine
Verified
Journal Article
Open access
PDF file
FBFulya Bakilan
Fulya Bakilan
BOBurcu Ortanca
Burcu Ortanca
AEAyşe Ekim
Ayşe Ekim
FMFezan Sahin Mutlu
Fezan Sahin Mutlu
Background/Aim: Considering the effects of inflammation on fibromyalgia and the small intestine, we hypothesize that vitamin D deficiency may contribute to inflammation and affect vitamin B12 and ferritin levels in patients with fibromyalgia. The objectives were: 1) to compare the levels of vitamin D, vitamin B12, and ferritin in patients with fibromyalgia and patients who have local painful conditions, and 2) to evaluate the correlation of vitamin D levels with vitamin B12 and ferritin levels. Methods: The records of 299 patients with fibromyalgia (274 female, 25 male) and 128 patients with local painful conditions (114 female, 14 male) between April 2019 and 2020 were examined, including measurements of 25-hydroxy vitamin D, vitamin B12, ferritin, erythrocyte sedimentation rate, and C-reactive protein. Results: The levels of 25-hydroxy vitamin D were low in both groups, with levels below 30 ng/ml in 90.3% of all patients. However, there was no significant difference in vitamin B12 and ferritin levels between the two groups, and the levels of these markers were within normal limits in both groups. Correlation analysis showed that vitamin D levels were significantly correlated with vitamin B12 (P<0.001, r=0.211) and ferritin (P=0.005, r=0.337) levels in patients with fibromyalgia but not in the other group. Conclusion: Consistent with our hypothesis, an association was found between vitamin D levels and vitamin B12 and ferritin levels in fibromyalgia. However, this correlation was not found in patients with local painful conditions. '+st+' Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33(2):160-72. doi: 10.1002/art.1780330203 DOI: https://doi.org/10.1002/art.1780330203 Arranz L, Canela M, Rafecas M. Fibromyalgia and nutrition, what do we know? Rheumatol Int. 2010;30(11):1417–27. doi: 10.1007/s00296-010-1443-0 DOI: https://doi.org/10.1007/s00296-010-1443-0 Ortancil O, Sanli A, Eryuksel R, Basaran A, Ankarali H. Association between serum ferritin level and fibromyalgia syndrome. Eur. J. Clin. Nutr. 2010;64(3):308-12. doi: 10.1038/ejcn.2009.149 DOI: https://doi.org/10.1038/ejcn.2009.149 Mader R, Koton Y, Buskila D, Herer P, Elias M. Serum iron and iron stores in non-anemic patients with fibromyalgia. Clin. Rheumatol. 2012;31(4):595-9. doi: 10.1007/s10067-011-1888-x DOI: https://doi.org/10.1007/s10067-011-1888-x Bottiglieri T. Homocysteine and folate metabolism in depression progress. Neuro-Psychopharmacol. Biol. Psychiatry. 2005;29(7):1103-12. doi: 10.1016/j.pnpbp.2005.06.021 DOI: https://doi.org/10.1016/j.pnpbp.2005.06.021 Zhang M, Han W, Hu S, Xu H. Methylcobalamin: a potential vitamin of pain killer. Neural Plast. 2013:424651. doi: 10.1155/2013/424651 DOI: https://doi.org/10.1155/2013/424651 De Carvalho JF, Silva DNF. Serum levels of vitamin B12 (cobalamin) in fibromyalgia. Rheumatology international. 2016;36(5):741-2. doi: 10.1007/s00296-016-3454-y DOI: https://doi.org/10.1007/s00296-016-3454-y Akar N, Çaglar NS, Aytekin E, Akar A, Aksu Ö, Öz N. Low levels of serum vitamin D3 are associated with fibromyalgia syndrome in pre-menopausal women: A pilot study. Turk J Phys Med Rehabil. 2020;66(1):67-72. doi: 10.3906/sag-1508-30 DOI: https://doi.org/10.5606/tftrd.2020.2928 Ozcan DS, Oken O, Aras M, Koseoglu BF. Vitamin D levels in women with fibromyalgia and relationship between pain, depression, and sleep. Turk J Phys Med Rehabil. 2014;60(4):329-35. doi: 10.5152/tftrd.2014.45143 DOI: https://doi.org/10.5152/tftrd.2014.45143 Özgen M, Aydoğan AM, Uygur A, Armağan O, Berkan F, Mutlu F. Fibromiyalji Sendromunda D Vitamin Düzeylerinin Değerlendirilmesi. OJM. 2018;41(2):161-5. doi: 10.20515/otd.459018 DOI: https://doi.org/10.20515/otd.459018 Backryd E, Tanum L, Lind AL, Larsson A, Gordh T. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res. 2017;10:515–25. doi: 10.2147/JPR.S128508 DOI: https://doi.org/10.2147/JPR.S128508 Rodriguez-Pinto I, Agmon-Levin N, Howard A, Shoenfeld Y. Fibromyalgia and cytokines. Immunol Lett. 2014;161(2):200–3. doi: 10.1016/j.imlet.2014.01.009 DOI: https://doi.org/10.1016/j.imlet.2014.01.009 Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37(11):1593–601. DOI: https://doi.org/10.1002/art.1780371106 Vasquez, A. Neuroinflammation in fibromyalgia and CRPS is multifactorial. Nat Rev Rheumatol. 2016;12:242. doi: 10.1038/nrrheum.2016.25 DOI: https://doi.org/10.1038/nrrheum.2016.25 Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology. 2008;47:1223–7. doi: 10.1093/rheumatology/ken140 DOI: https://doi.org/10.1093/rheumatology/ken140 Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann. Rheum. Dis. 2004;63(4):450-2. doi: 10.1136/ard.2003.011502 DOI: https://doi.org/10.1136/ard.2003.011502 Peuhkuri K, Vapaatalo H, Korpela R. Even low-grade inflammation impacts on small intestinal function. World journal of gastroenterology. 2010;16(9):1057-62. doi: 10.3748/wjg.v16.i9.1057 DOI: https://doi.org/10.3748/wjg.v16.i9.1057 Mourad FH, Barada KA, Bou Rached NA, Khoury CI, Saadé NE, Nassar CF. Inhibitory effect of experimental colitis on fluid absorption in rat jejunum: role of the enteric nervous system, VIP, and nitric oxide. Am J Physiol Gastrointest Liver Physiol. 2006;290:262-8. doi: 10.1152/ajpgi.00271.2005 DOI: https://doi.org/10.1152/ajpgi.00271.2005 Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe‐Court D, Boucher BJ. Circulating MMP9, vitamin D and variation in the TIMP‐1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? Qjm. 2002;95(12):787-96. doi: 10.1093/qjmed/95.12.787 DOI: https://doi.org/10.1093/qjmed/95.12.787 RafteryT, Martineau AR, Greiller CL, Ghosh S, McNamara D, Bennett K, et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. doi: 10.1177/2050640615572176 DOI: https://doi.org/10.1177/2050640615572176 Bashir M, Prietl B, Tauschmann M, Mautner SI, Kump PK, Treiber G, et al. Effects of high doses of vitamin D 3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. European journal of nutrition. 2016;55(4):1479-89. doi: 10.1007/s00394-015-0966-2 DOI: https://doi.org/10.1007/s00394-015-0966-2 Smith EM, Samadian S. Use of the erythrocyte sedimentation rate in the elderly. Br J Hosp Med. 1994;51:394-7. doi: 10.3906/sag-1710-81 DOI: https://doi.org/10.3906/sag-1710-81 Block SR. Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. In Mayo Clinic Proceedings. 2004;79(12):1585-6. doi: 10.4065/79.12.1585 DOI: https://doi.org/10.4065/79.12.1585 Atalay SG, Atalay R, Alkan BM, Fidan F, Bozkurt S, Aksekili H. Vitamin D deficiency in adults with musculoskeletal pain. Turk J Osteoporos. 2015;21(3):101-4. DOI: https://doi.org/10.4274/tod.19981 Ösken S, İçağasıoğlu A, Arslan P, Eğilmez Z, Murat S. D Vitamininin Kognitif Fonksiyonlarla İlişkisi: Genç Erişkin Kadınlarda Kesitsel Bir Çalışma. Turk J Osteoporos. 2016;22:137-40. DOI: https://doi.org/10.4274/tod.09326 Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117-45. doi: 10.1146/annurev.nutr.23.011702.073114 DOI: https://doi.org/10.1146/annurev.nutr.23.011702.073114 Stumpf WE, Hayakawa N, Koike N, Hirate J, Okazaki, A. Nuclear receptors for 1, 25-dihydroxy-22-oxavitamin D 3 (OCT) and 1, 25-dihydroxyvitamin D 3 in gastric gland neck mucous cells and gastrin enteroendocrine cells. Histochem. Cell Biol. 1995;103(4):245-50. DOI: https://doi.org/10.1007/BF01457407 Antico A, Tozzoli R, Giavarina D, Tonutti E, Bizzaro N. Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case–control study and review of the literature on the interaction of vitamin D with the immune system. Clin Rev Allergy Immunol. 2012;42(3):355-64. doi: 10.1007/s12016-011-8255-1 DOI: https://doi.org/10.1007/s12016-011-8255-1 Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol. 1999;26(7):1564–9. Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K, et al. Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain. 2007;8(9):737–45. doi: 10.1016/j.jpain.2007.05.002 DOI: https://doi.org/10.1016/j.jpain.2007.05.002 Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E. Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol. 2012;242(1–2):33–8. doi: 10.1016/j.jneuroim.2011.10.013 DOI: https://doi.org/10.1016/j.jneuroim.2011.10.013 Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain. 2014;155(2):261-8. doi: 10.1016/j.pain.2013.10.002 DOI: https://doi.org/10.1016/j.pain.2013.10.002 Hur J, Lee P, Kim MJ, Cho YW. Regulatory effect of 25-hydroxyvitamin D3 on nitric oxide production in activated microglia. Korean J. Physiol. Pharmacol. 2014;18:397–402. doi: 10.4196/kjpp.2014.18.5.397 DOI: https://doi.org/10.4196/kjpp.2014.18.5.397 Luthold RV, Fernandes GR, Franco-de-Moraes AC, Folchetti LG, Ferreira SR. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals. Metabolism. 2017;69:76-86. doi: 10.1016/j.metabol.2017.01.007 DOI: https://doi.org/10.1016/j.metabol.2017.01.007 Littlejohn, G. Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Nat. Rev. Rheumatol. 2015;11:639–48. doi: 10.1038/nrrheum.2015.100 DOI: https://doi.org/10.1038/nrrheum.2015.100 Curic N, Ilincic B, Milic N, Cabarkapa V, Nikolic S, Medic-Stojanoska M. The relationship between the vitamin serum 25 (OH) D and the B12 concentrations in obese women. Minerva medica. 2018;109(2):79-87. doi: 10.23736/s0026-4806.17.05447-7 DOI: https://doi.org/10.23736/S0026-4806.17.05447-7 Miller AA, Spencer SJ. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun. 2014;42:10-21. doi: 10.1016/j.bbi.2014.04.001 DOI: https://doi.org/10.1016/j.bbi.2014.04.001 Aguilar-Valles A, Inoue W, Rummel C, Luheshi GN. Obesity, adipokines and neuroinflammation. Neuropharmacology. 2015;96:124-34. doi: 10.1016/j.neuropharm.2014.12.023. DOI: https://doi.org/10.1016/j.neuropharm.2014.12.023 Copyright (c) 2023 Fulya Bakılan , Burcu Ortanca, Ayşe Ekim, Fezan Şahin Mutlu This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

1 August 2018 in Turkish Journal of Osteoporosis
Verified
Journal Article
Closed access
FBFulya Bakilan
Fulya Bakilan
SÖSibel Ösken
Sibel Ösken
AEAyşe Ekim
Ayşe Ekim

20 October 2023 in Eskisehir Medical Journal, Eskisehir City Hospital
Verified
Journal Article
Closed access
FBFulya Bakilan
Fulya Bakilan
BOBurcu Ortanca
Burcu Ortanca
AEAyşe Aydemir Ekim
Ayşe Aydemir Ekim
OAOnur Armağan
Onur Armağan
Introduction: The objective was to compare the rate and localization of trigger points and muscle strength in patients with and without pes planus. Methods: A total of 88 female patients were divided into two groups according to the presence (with the mean age of 32.50 ± 7.95) (n=52) or absence of pes planus (with the mean age of 33.5 ± 7.80) (n=36). Muscle strength was evaluated with handgrip-strength, leg-back strength. The presence of trigger points (present/absent), the pain region of trigger points (masseter muscle, cervical/thoracic/lumber regions, upper/lower extremity) and the Visual Analog-Scale for pain severity were detected. Results: The rate of trigger points was significantly higher in the pes planus group in all regions: in the masseter muscle (p=0.042), upper extremities (p=0.006), cervicotorasic region (p=0.020), lumbar region (p=0.014), and lower extremities (p=0.020). 98.1% of the patients with pes planus were found to have at least one trigger point. The pain severity of trigger points was significantly higher in pes planus group (p=0.037). However muscle strength were found to be significantly similar between the groups. Conclusion: A significant relationship was found between pes planus and the rate of having trigger points not only in lower extremities and lumbar region, but also in masseter, upper extremities and the servicotorasic region in females. However, any relationship were not found between pes planus and muscle strength.

1 April 2022 in Turkish Journal of Osteoporosis
Verified
Journal Article
Open access
HHHATİCE HAMARAT
HATİCE HAMARAT
GYGöknur Yorulmaz
Göknur Yorulmaz
AAAyşe Ekim Aydemir
Ayşe Ekim Aydemir
EGEmel Gönüllü
Emel Gönüllü
AMAhmet Musmul
Ahmet Musmul
SGSinem Gurcu
Sinem Gurcu